iodoxamic acid

Known as: 3,3'-((1,16-dioxo-4,7,10,13-tetraoxahexadecane-1,16-dily)diimino)bis(2,4,6-triiodobenzoic acid), iodoxamidic acid, iodoxaminic acid 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-1982
024619731982

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1980
1980
The pharmacokinetics, biliary excretion, plasma protein binding, enterohepatic circulation, and biotransformation of iopanoic… (More)
Is this relevant?
1979
1979
No differences could be detected subjectively in the quality of cholangiograms after the use of varying amounts of contrast… (More)
Is this relevant?
1979
1979
The dynamic method originally developed for studying the capacity-limited kinetics of the cholecystographic agents iodoxamic acid… (More)
Is this relevant?
1978
1978
The previously reported steady-state method allowed estimation of the capacity-limited pharmacokinetics of the cholangiographic… (More)
Is this relevant?
1978
1978
Bile flow and the biliary excretion of indocyanine green, bromcresol green, eosine, bromsulphthalein-glutathione conjugate (BSP… (More)
Is this relevant?
1978
1978
The general, neural and cardiovascular tolerance of iotroxic acid (Biliscopin) and its deleterious effect on membranes were… (More)
Is this relevant?
1976
1976
Intravenous contrast media must have an optimum biliary excretion and a small urinary excretion, also a good tolerability. These… (More)
Is this relevant?
1976
1976
Pharmaco-kinetic studies of the cholecystographic contrast medium iodoxaminic acid (Diglumin-Iodaxamate) which is characterised… (More)
Is this relevant?
1976
1976
The biotransformation of the 131I-labeled cholegraphic media ioglycamic acid, iodoxamic acid and iotroxic acid in man is… (More)
Is this relevant?